159 related articles for article (PubMed ID: 25075803)
1. The weight of MMRV-related febrile convulsions among other clinical factors contributing to febrile convulsions in children.
Gavrielov-Yusim N; Hoshen M; Singer SR; Neumann L; Balicer RD
Vaccine; 2014 Sep; 32(39):4954-9. PubMed ID: 25075803
[TBL] [Abstract][Full Text] [Related]
2. Risk of febrile convulsions after MMRV vaccination in comparison to MMR or MMR+V vaccination.
Schink T; Holstiege J; Kowalzik F; Zepp F; Garbe E
Vaccine; 2014 Feb; 32(6):645-50. PubMed ID: 24374498
[TBL] [Abstract][Full Text] [Related]
3. Combined measles-mumps-rubella-varicella vaccine and febrile convulsions: the risk considered in the broad context.
Casabona G; Berton O; Singh T; Knuf M; Bonanni P
Expert Rev Vaccines; 2023; 22(1):764-776. PubMed ID: 37642012
[TBL] [Abstract][Full Text] [Related]
4. Modelling Hospitalisation Ratios for Febrile Convulsions and Severe Varicella Under Combined Measles, Mumps, Rubella, and Varicella (MMRV-Priorix-Tetra™) Compared to Separate MMR + V Vaccination.
Bauchau V; Van Holle L; Cohen C
Drug Saf; 2015 Nov; 38(11):1095-102. PubMed ID: 26251259
[TBL] [Abstract][Full Text] [Related]
5. Impact of history of febrile convulsions on the risk difference of febrile convulsions with the tetravalent measles-mumps-rubella-varicella vaccine: Post-hoc exploratory analysis of results from a matched-cohort study.
Gvozdenovic E; Vetter V; Willame C; Rosillon D
Vaccine; 2018 Sep; 36(39):5803-5806. PubMed ID: 30131195
[TBL] [Abstract][Full Text] [Related]
6. Safety of measles-containing vaccines in 1-year-old children.
Klein NP; Lewis E; Fireman B; Hambidge SJ; Naleway A; Nelson JC; Belongia EA; Yih WK; Nordin JD; Hechter RC; Weintraub E; Baxter R
Pediatrics; 2015 Feb; 135(2):e321-9. PubMed ID: 25560438
[TBL] [Abstract][Full Text] [Related]
7. Second dose of measles-mumps-rubella-varicella vaccine (MMRV) and the risk of febrile convulsions.
Schäfer W; Reinders T; Schink T
Vaccine; 2022 Mar; 40(14):2168-2172. PubMed ID: 35232594
[TBL] [Abstract][Full Text] [Related]
8. Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures.
Klein NP; Fireman B; Yih WK; Lewis E; Kulldorff M; Ray P; Baxter R; Hambidge S; Nordin J; Naleway A; Belongia EA; Lieu T; Baggs J; Weintraub E;
Pediatrics; 2010 Jul; 126(1):e1-8. PubMed ID: 20587679
[TBL] [Abstract][Full Text] [Related]
9. Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting.
Jacobsen SJ; Ackerson BK; Sy LS; Tran TN; Jones TL; Yao JF; Xie F; Cheetham TC; Saddier P
Vaccine; 2009 Jul; 27(34):4656-61. PubMed ID: 19520201
[TBL] [Abstract][Full Text] [Related]
10. Measles-containing vaccines and febrile seizures in children age 4 to 6 years.
Klein NP; Lewis E; Baxter R; Weintraub E; Glanz J; Naleway A; Jackson LA; Nordin J; Lieu T; Belongia EA; Fireman B
Pediatrics; 2012 May; 129(5):809-14. PubMed ID: 22473362
[TBL] [Abstract][Full Text] [Related]
11. Febrile seizures and measles-mumps-rubella-varicella (MMRV) vaccine: what do primary care physicians think?
O'Leary ST; Suh CA; Marin M;
Vaccine; 2012 Nov; 30(48):6731-3. PubMed ID: 22975026
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Combination Measles-Mumps-Rubella-Varicella Vaccine Introduction in Australia.
Macartney K; Gidding HF; Trinh L; Wang H; Dey A; Hull B; Orr K; McRae J; Richmond P; Gold M; Crawford N; Kynaston JA; McIntyre P; Wood N;
JAMA Pediatr; 2017 Oct; 171(10):992-998. PubMed ID: 28806450
[TBL] [Abstract][Full Text] [Related]
13. Risk of febrile seizures after first dose of measles-mumps-rubella-varicella vaccine: a population-based cohort study.
MacDonald SE; Dover DC; Simmonds KA; Svenson LW
CMAJ; 2014 Aug; 186(11):824-9. PubMed ID: 24914115
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
Vesikari T; Baer M; Willems P
Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
[TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of early vaccination with two doses of tetravalent measles-mumps-rubella-varicella (MMRV) vaccine in healthy children from 9 months of age.
Goh P; Lim FS; Han HH; Willems P
Infection; 2007 Oct; 35(5):326-33. PubMed ID: 17710370
[TBL] [Abstract][Full Text] [Related]
16. A postmarket safety comparison of 2 vaccination strategies for measles, mumps, rubella and varicella in Italy.
Cocchio S; Zanoni G; Opri R; Russo F; Baldo V;
Hum Vaccin Immunother; 2016 Mar; 12(3):651-4. PubMed ID: 26528829
[TBL] [Abstract][Full Text] [Related]
17. Febrile seizures following measles and varicella vaccines in young children in Australia.
Macartney KK; Gidding HF; Trinh L; Wang H; McRae J; Crawford N; Gold M; Kynaston A; Blyth C; Yvonne Z; Elliott E; Booy R; Buttery J; Marshall H; Nissen M; Richmond P; McInytre PB; Wood N;
Vaccine; 2015 Mar; 33(11):1412-7. PubMed ID: 25444797
[TBL] [Abstract][Full Text] [Related]
18. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.
Lieberman JM; Williams WR; Miller JM; Black S; Shinefield H; Henderson F; Marchant CD; Werzberger A; Halperin S; Hartzel J; Klopfer S; Schödel F; Kuter BJ;
Pediatr Infect Dis J; 2006 Jul; 25(7):615-22. PubMed ID: 16804432
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life.
Schuster V; Otto W; Maurer L; Tcherepnine P; Pfletschinger U; Kindler K; Soemantri P; Walther U; Macholdt U; Douha M; Pierson P; Willems P
Pediatr Infect Dis J; 2008 Aug; 27(8):724-30. PubMed ID: 18600190
[TBL] [Abstract][Full Text] [Related]
20. Similar relative risks of seizures following measles containing vaccination in children born preterm compared to full-term without previous seizures or seizure-related disorders.
McClure DL; Jacobsen SJ; Klein NP; Naleway AL; Kharbanda EO; Glanz JM; Jackson LA; Weintraub ES; McLean HQ
Vaccine; 2019 Jan; 37(1):76-79. PubMed ID: 30478005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
